Brain Cross‐Protection against SARS‐CoV‐2 Variants by a Lentiviral Vaccine in New Transgenic Mice - Archive ouverte HAL Access content directly
Journal Articles EMBO Molecular Medicine Year : 2021

Brain Cross‐Protection against SARS‐CoV‐2 Variants by a Lentiviral Vaccine in New Transgenic Mice

(1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (2) , (2) , (3) , (1) , (4) , (2) , (1) , (1)
1
2
3
4
François Anna
Catherine Blanc

Abstract

COVID-19 vaccines already in use or in clinical development may have reduced efficacy against emerging SARS-CoV-2 variants. In addition, although the neurotropism of SARS-CoV-2 is well established, the vaccine strategies currently developed have not taken into account protection of the central nervous system. Here, we generated a transgenic mouse strain expressing the human Angiotensin Converting Enzyme 2, and displaying unprecedented brain permissiveness to SARS-CoV-2 replication, in addition to high permissiveness levels in the lung. Using this stringent transgenic model, we demonstrated that a non-integrative lentiviral vector, encoding for the spike glycoprotein of the ancestral SARS-CoV-2, used in intramuscular prime and intranasal boost elicits sterilizing protection of lung and brain against both the ancestral virus, and the Gamma (P.1) variant of concern, which carries multiple vaccine escape mutations. Beyond induction of strong neutralizing antibodies, the mechanism underlying this broad protection spectrum involves a robust protective T-cell immunity, unaffected by the recent mutations accumulated in the emerging SARS-CoV-2 variants.
Fichier principal
Vignette du fichier
emmm.202114459.pdf (29.32 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-03388768 , version 1 (20-10-2021)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Min-Wen Ku, Pierre Authié, Maryline Bourgine, François Anna, Amandine Noirat, et al.. Brain Cross‐Protection against SARS‐CoV‐2 Variants by a Lentiviral Vaccine in New Transgenic Mice. EMBO Molecular Medicine, 2021, pp.e14459. ⟨10.15252/emmm.202114459⟩. ⟨pasteur-03388768⟩
137 View
45 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More